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Several lines of evidence suggest that mitochondrial
dysfunction plays a critical role in the pathogenesis
of microvascular complications of diabetes,
including diabetic nephropathy. However, the
signaling pathways by which hyperglycemia leads
to mitochondrial dysfunction are not fully under-
stood. Here we examined the role of Rho-associated
coiled coil-containing protein kinase 1 (ROCK1) on
mitochondrial dynamics by generating two diabetic
mouse models with targeted deletions of ROCK1
and an inducible podocyte-specific knockin mouse
expressing a constitutively active (cA) mutant of
ROCK1. Our findings suggest that ROCK1 mediates
hyperglycemia-induced mitochondrial fission by
promoting dynamin-related protein-1 (Drp1) recruit-
ment to the mitochondria. Deletion of ROCK1 in dia-
betic mice prevented mitochondrial fission, whereas
podocyte-specific cA-ROCK1 mice exhibited
increased mitochondrial fission. Importantly, we
found that ROCK1 triggers mitochondrial fission by
phosphorylating Drp1 at serine 600 residue. These
findings provide insights into the unexpected role
of ROCK1 in a signaling cascade that regulates mito-
chondrial dynamics.
INTRODUCTION
Diabetes is the most common metabolic disease in the world
and a leading cause of blindness, end-stage renal disease, and
nontraumatic loss of limb. Although there is considerable
evidence suggesting that chronic hyperglycemia is the main
culprit for microvascular complications of diabetes, the under-
lying molecular mechanism of diabetic complications remains
poorly understood. Using cultured aortic endothelial cells, Nish-
ikawa et al. (Nishikawa et al., 2000) provided experimental186 Cell Metabolism 15, 186–200, February 8, 2012 ª2012 Elsevier Inevidence that hyperglycemia leads to overproduction of reactive
oxygen species (ROS), which was then prevented by overex-
pression of uncoupling protein-1 and manganese superoxide
dismutase. These observations have led to the ‘‘unifying hypoth-
esis’’ whereby increased mitochondrial ROS production was
proposed to serve as the common link for several key patho-
genic pathways involved in microvascular complications of dia-
betes (Brownlee, 2001; Nishikawa et al., 2000). However, the
specific signaling molecules that couple hyperglycemia with
mitochondrial ROS production and the nature of mitochondrial
dysfunction associated with cell apoptosis in the diabetic milieu
remain to be defined.
Rho-associated coiled coil-containing protein kinase (ROCK)
is a downstream effector of RhoA that is believed to play a key
role in mediating the effects of RhoA on stress fiber formation,
ROS production, and cellular apoptosis (Noma et al., 2008;
Ongusaha et al., 2008; Riento and Ridley, 2003). We have previ-
ously shown that pharmacological inhibition of ROCK by fasudil
ameliorates albuminuria and progression of diabetic nephrop-
athy (DN) in an established mouse model of diabetes (Kolavennu
et al., 2008). Other laboratories have reported complementary
data, suggesting that the ROCK pathway may play an important
role in the pathogenesis of DN (Gojo et al., 2007; Kikuchi et al.,
2007; Peng et al., 2008). However, fasudil is not a selective inhib-
itor of ROCK, and it may inhibit other serine/threonine kinases
such as protein kinases A and C (PKA, PKC) at high concentra-
tions (Davies et al., 2000; Sasaki et al., 2002). Moreover, the use
of fasudil cannot distinguish the individual roles of the two iso-
forms of ROCK, ROCK1 and ROCK2, in the progression of DN.
Importantly, despite an emerging role for ROCK in DN, the
underlying molecular mechanisms for its pathogenic effect are
unknown. To address these questions, in the current study we
tested the hypothesis that ROCK1 activation promotes progres-
sion of DN by triggering mitochondrial dysfunction.
Mitochondrial dynamics have emerged as an important pro-
cess that contributes to mitochondrial dysfunction in a variety
of metabolic conditions, including in the diabetic milieu (Yu
et al., 2006). Mitochondria are dynamic organelles that fre-
quently change their shape, number, and intracellular distribu-
tion in response to fluctuations in metabolic demands. Underc.
Cell Metabolism
ROCK1 and Mitochondrial Dynamics
Cell Metabolism 15, 186–200, February 8, 2012 ª2012 Elsevier Inc. 187
Cell Metabolism
ROCK1 and Mitochondrial Dynamicsphysiological conditions, mitochondria are elongated and fila-
mentous, but they undergo extensive fragmentation during
apoptosis (Youle and Karbowski, 2005). Several studies have
indicated that excessive mitochondrial fission is associated
with increased ROS production and cellular apoptosis (Tanaka
and Youle, 2008; Youle and Karbowski, 2005). Interestingly,
in vitro studies have also implicated mitochondrial fission as
a key mediator of increased ROS production and cellular
apoptosis under hyperglycemic conditions (Rube and van der
Bliek, 2004; Yu et al., 2006). However, these studies have been
limited to tissue culture cells, and the precise role of mitochon-
drial dynamics in the diabetic milieu and its complications in vivo
remain to be explored.
Here we report that ROCK1 plays a critical role in progression
of DN by triggeringmitochondrial fission, which results in recruit-
ment of dynamin-related protein-1 (Drp1) to the mitochondria.
Thus, our findings identify ROCK1 as a potent regulator of mito-
chondrial dynamics, and shed light into the critical role of ROCK1
in progression of DN.
RESULTS
Albuminuria Is Markedly Decreased in Mice Lacking
ROCK1 in Several Experimental Models of Diabetes
We generated two diabetic mice models with targeted deletion
of ROCK1 to assess the specific role of ROCK1 in DN. First,
we used ROCK1 null (ROCK1/) and Leprdb/+ mice to generate
diabetic Leprdb/db ROCK1/ mice (hereafter referred to as db/
db:ROCK1/). Western blotting confirmed absence of ROCK1
protein in the kidney, heart, and spleen (Figure 1A). Four groups
of mice were investigated: db/+:ROCK1+/+, db/+:ROCK1/,
diabetic db/db:ROCK1+/+, and diabetic db/db:ROCK1/
mice. Basic parameters, including systolic blood pressure,
body weight, kidney weight, plasma glucose, and urinary
albumin excretion, were determined for each animal. Compar-
ison of the nondiabetic ROCK1 knockout mice with their control
wild-type (WT) littermates showed that the knockout animals did
not differ significantly fromWT in any of these parameters, which
is in general agreement with previous reports (Chang et al., 2006;
Haudek et al., 2009; Zhang et al., 2006). Double mutant diabetic
mice (db/db:ROCK1/) were similar to diabetic db/
db:ROCK1+/+ mice for blood pressure, body weight, kidney
weight/body weight, and serum glucose levels (Figures 1B–
1G), However, a marked reduction in the urinary albumin excre-Figure 1. Deletion of ROCK1 Significantly Reduced Albuminuria and M
(A) A representative western blot confirming deletion of ROCK1 in several tissu
unchanged in the same tissues (lower panel).
(B) Representative pictures of mice in each group at 24 weeks of age.
(C and D) Systolic blood pressure (C) and body weight (D) were measured in 24-
(E) Representative images of kidneys obtained from 24-week-old mice.
(F) Kidney weight/body weight ratio in each group.
(G) Blood glucose levels in each group. * represents significant statistical differen
(H) Urinary albumin excretion was measured at 16 weeks and 24 weeks of age.
(I) Representative images of periodic acid-Schiff (PAS) staining of kidney sections
Index in each group (right panel).
(J) Representative electron photomicrographs of glomerular basement membra
group (right panel).
(K) Podocyte numbers were quantified by assessing nuclear WT1 staining in 5
presented as mean ± SEM (n = 5–8/group) in all figures and analyzed by one-wa
188 Cell Metabolism 15, 186–200, February 8, 2012 ª2012 Elsevier Intion was observed in the diabetic db/db:ROCK1/ mice
compared with that in db/db:ROCK1+/+ mice at 16 weeks of
age (346 ± 106 versus 227 ± 106 mg/mg, p < 0.05) (Figure 1H).
Consistent with the biochemical changes in the urine, periodic
acid-Schiff (PAS) staining also revealed a significant reduction
in mesangial matrix expansion in db/db:ROCK1/ mice com-
pared with that in db/db:ROCK1+/+ diabetic mice by 24 weeks
of age (Figure 1I). Furthermore, the glomerular basement
membrane thickness was reduced (Figure 1J), and the loss of
podocytes was prevented in db/db: ROCK1/mice (Figure 1K).
To evaluate the consequences of targeted deletion of ROCK1
in a different model of DN, ROCK1+/+ and ROCK1/mice were
made diabetic with streptozotocin (STZ). Since we used a high
dose of STZ to induce proteinuria (Chow et al., 2006), diabetic
mice were monitored for 16–24 weeks after STZ injections to
avoid potential acute kidney injury associated with STZ adminis-
tration in the first 6–8 weeks. Our findings indicate that diabetic
ROCK1/ and ROCK1+/+ mice exhibited similar weights, blood
pressure, and blood glucose levels 16 weeks post-STZ injection,
but knockout of ROCK1 prevented the marked increase in the
diabetes-induced kidney weight/body weight ratio (Figures 2A–
2D). Importantly, the increase in the urinary albumin excretion
and enhanced mesangial matrix expansion observed in diabetic
control mice after 16 weeks of hyperglycemia were prevented in
diabetic ROCK1/ mice (Figures 2E and 2F). Furthermore,
consistent with a renoprotective effect of ROCK1/, the
glomerular basement membrane thickness and podocyte
numbers were preserved in diabetic ROCK1/ mice (Figures
2G and 2H). Taken together, these results demonstrate a critical
role of ROCK1 activation in DN and suggest that targeted dele-
tion of ROCK1 is renoprotective in both type 1 and type 2models
of diabetes.
Inducible Cre-Recombinase Activation of
Podocyte-Specific cA-ROCK1 Bitransgenic Mice
Causes Albuminuria
To understand the role of ROCK1 overexpression in the develop-
ment of albuminuria, we generated a conditionally inducible
knockin of constitutively active (cA) ROCK1 by targeting cA-
ROCK1 into the ROSA 26 locus through homologous recombi-
nation. The strategy for generating cA-ROCK1 knockin mouse
is shown in Figure 3A. We generated a targeting vector carrying
the cA-human ROCK1 mutant and a transcriptional stop
cassette flanked by LoxP recombination sites upstream of theesangial Matrix Expansion in the Kidneys of db/db Mice
es in Leprdb/+:ROCK1/ mice (upper panel). ROCK2 expression levels were
week-old mice in each group. NS: not significant.
ces between diabetic and nondiabetic mice (p < 0.01).
(left panel; original magnification, 4003) and quantification of Mesangial Matrix
ne (GBM) thickening (left panel) and quantification of GBM thickness in each
0 randomly selected kidney glomeruli per animal in each group. Results are
y ANOVA.
c.
Figure 2. Deletion of ROCK1 Ameliorated Albuminuria in STZ-Induced Diabetic Mice
(A) Representative images of mice (left panel), kidneys (middle panel), and histology (right panel) of nondiabetic and diabetic ROCK1/ and ROCK1+/+ mice.
Histological analysis was assessed by PAS staining (original magnification, 4003).
(B and C) Systolic blood pressure (B) and kidney weight/body weight ratio (C) in 24-week-old mice in each group.
(D) Blood glucose levels in each group. * represents significant statistical differences between diabetic and nondiabetic mice (p < 0.01).
(E) Albumin/creatinine ratio was measured in mice after 8 and 16 weeks of persistent hyperglycemia.
(F) Mesangial Matrix Index was measured in each group.
(G) Representative electron photomicrographs of GBM thickening (left panel) and quantification of GBM thickness in each group (right panel).
(H) Podocyte numbers were quantified by assessing nuclear WT1 staining in each group. All data are presented as means ± SEM (n = 8–12/each group) and
analyzed by one-way ANOVA.
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introduction of Cre recombinase. Two transgenic mouse lines
that showed germline transmission of the transgene were
selected andmaintained for further studies. Offspring genotypes
from heterozygous mating followed Mendelian frequencies. ToCell Minvestigate the role of ROCK1 specifically in podocytes,
we crossed RosacA-ROCK1 transgenic mice (TgcA-ROCK1flox/+)
with an inducible podocyte-specific Cre transgenic line
(Tgpodocin-iCreERT2/+) to generate single-copy cA-ROCK1 overex-
pression in podocytes (Figure 3B). The podocyte-specific Creetabolism 15, 186–200, February 8, 2012 ª2012 Elsevier Inc. 189
Figure 3. Generation and Initial Characterization of Inducible Podocin Cre cA-ROCK1 Knockin Mice
(A) The schematic diagram illustrates the ROSA26 targeting locus, cA-ROCK1 targeting construct, and the conditional allele after homologous recombination.
The ubiquitin C promoter (UbiC; green arrow) was used to drive constitutively active ROCK1 cDNA (cA-ROCK1; blue arrow) expression.
(B) Breeding scheme of bitransgenic podocin Cre cA-ROCK1 mice.
(C) Gross appearances of control and inducible podocin Cre cA-ROCK1 knockin mice.
(D) ROCK1 activity in the kidney glomeruli was performed by assessing p-MYPT in podocin Cre cA-ROCK1 knockin mice (left panel). Quantitation of phospho-
myosin phosphatase target subunit 1 (p-MYPT1) in each group (right panel).
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the control of the podocin promoter, was previously gener-
ated in our laboratory (Wang et al., 2010). The use of iCreERT2
allowed us to control expression of floxed cA-ROCK1 in the
presence of tamoxifen in a temporal-specific manner in
podocytes. We generated mice that were heterozygous for the
floxed cA-ROCK1 and carried the podocin Cre transgene
(TgcA-ROCK1flox/+;Tgpodocin-iCre/+) and then activated podocin Cre
by administrating tamoxifen to bitransgenic mice at a dose of
2 mg/day/mouse for a total of ten injections by 8 weeks of age
(Wang et al., 2010). The Cre-activated bitransgenic mice (here-
after referred to as podocin Cre cA-ROCK1) were indistinguish-
able in size from their control littermate mice (TgcA-ROCK1flox/+ or
Tgpodocin-iCre/+, hereafter referred to as control mice) (Figure 3C).
We assessed ROCK1 activation in the glomeruli of 15-week-old
mice by isolating glomeruli from podocin Cre cA-ROCK1 mice
5 weeks after induction with tamoxifen (Figures S1A–S1C).
ROCK1 activation assay revealed a 3.5-fold increase of
ROCK1 activation in the kidney glomeruli (Figure 3D), whereas
it was unchanged in other tissues (Figure S1D). Analysis of the
inducible podocin Cre cA-ROCK1 mice showed significant
increase in albuminuria (from 29 ± 2 to 77 ± 9 and 75 ±
6 mg/mg, p < 0.05) following 2 and 5 weeks of tamoxifen injection
(Figure 3E), while no significant changes were observed on their
blood pressure, body weight, blood glucose, and serum creati-
nine levels compared with their control littermates at 24 weeks
of age (Figure 3F). Histologically, 5 weeks after induction,
glomeruli frompodocin Cre cA-ROCK1mice exhibited increased
mesangial matrix accumulation (Figure 3G). However, enhanced
mesangial matrix was not observed consistently in all glomeruli.
The main histological change was effacement of foot processes
in podocytes in podocin Cre cA-ROCK1 mice on electron
microscopy (Figure 3H). Furthermore, podocyte numbers were
significantly reduced in podocin Cre cA-ROCK1 mice (Figure 3I).
Taken together, these data demonstrate that podocyte-specific
knockin of cA-ROCK1 promotes albuminuria, podocyte efface-
ment, and matrix expansion.
Deletion of ROCK1 Prevents Glomerular Apoptosis
and Mitochondrial ROS Production in Vivo
We next explored the precise mechanisms for ROCK1-induced
albuminuria. ROCK1 activation can induce apoptosis, and
growing evidence has shown that mitochondrial ROS (mtROS)
and apoptosis are critical in the pathogenesis of microvascular
complications of diabetes, including DN (Coughlan et al., 2007;
de Cavanagh et al., 2008; Kiritoshi et al., 2003; Nishikawa
et al., 2000). Therefore, we tested the effect of ROCK1 onmtROS
production in the glomeruli of control and STZ-induced diabetic
mice. To specifically assess mitochondrial superoxide produc-
tion, we performed Electron Paramagnetic Resonance (EPR)(E) Albumin/creatinine ratio in podocin Cre cA-ROCK1 knockin mice at 2 and 5 w
(F) Systolic blood pressure, blood glucose, body weights, and serum creatinine
(G) Photomicrographs of PAS staining from glomeruli of podocin Cre cA-ROCK1 (
Index in each group (right panel).
(H) Representative electron micrographs of kidneys (left panel) and quantificatio
arrows, and effacement of these processes is indicated by asterisks.
(I) Podocyte numbers were quantified in each group as previously described. Al
one-way ANOVA.
Cell Mspectroscopy and used 1-hydroxy-3-methoxycarbonyl-2,2,5,5-
tetramethyl-pyrrolidine (CMH) as the spin trap (Piskernik et al.,
2008; Pospisilik et al., 2007). We observed 8-fold increase in
the mtROS generation from the isolated kidney glomeruli of dia-
betic WT mice, whereas this increase was prevented in diabetic
ROCK1/mice (Figure 4A, left panel). The number of apoptotic
cells and the caspase-3 activity within the glomeruli of diabetic
ROCK/ mice were also significantly reduced compared to
that in WT diabetic mice (Figure 4A, middle and right panels).
Conversely, mtROS, frequency of apoptosis, and caspase-3
activity were all significantly increased in podocin Cre cA-
ROCK1 mice (Figure 4B).
To elucidate themechanisms by which deletion of ROCK1 can
prevent cellular apoptosis, we carried out cell fractionation
experiments to determine the effect of ROCK1 on the proapo-
ptotic factors Bax and cytochrome c. Bax activation leads to
its translocation to the outer mitochondrial membrane, where it
can permeabilize themitochondrial membrane by forming pores,
allowing release of cytochrome c. We assessed Bax protein
levels in the mitochondrial fractions and found that ROCK1 defi-
ciency led to significant decreases in the diabetic mice when
compared with WT diabetic mice (Figure 4C). In contrast, mito-
chondrial levels of cytochrome c were significantly increased in
diabetic ROCK1/ mice (Figure 4C, right panel). Collectively,
these data indicate that ROCK1 may be involved in increased
mitochondrial superoxide production and diabetic-induced
cellular apoptosis in the kidney glomeruli.
ROCK1 Mediates Diabetic-Induced Mitochondrial
Fission In Vivo
Recent published work indicates that mitochondrial fission
couples mitochondrial ROS with cell apoptosis in hyperglycemic
conditions (Yu et al., 2006). However, two important questions
remain to be addressed. First, it is unclear whether ROCK1medi-
ates hyperglycemia-induced mitochondrial fission, and second,
it remains unknown whether ROCK1 plays a role in the patho-
genesis of DN. Thus, to uncover the effect of the diabetic milieu
and ROCK1 onmitochondrial dynamics in the kidneys in vivo, we
examined the mitochondrial morphology in the kidney glomeruli
isolated from STZ-induced diabetic ROCK1/ mice. In WT
diabetic mice, electron microscopy revealed increased mito-
chondrial fragmentation, as evidenced by a significant increase
in small, punctate mitochondria in podocytes compared to those
in nondiabetic control mice, which exhibited long filamentous
mitochondria (Figure 4D). However, the increased mitochondrial
fragmentation in podocytes was prevented in diabetic
ROCK1/mice. To quantify changes in mitochondrial fragmen-
tation in podocytes, we determined the aspect ratio (AR) of
mitochondria in each group (Brooks et al., 2007; Yu et al.,
2006). WT diabetic mice exhibit 50% reduction of the AR ratioeeks post-tamoxifen injection.
were assessed in podocin Cre cA-ROCK1 mice.
original magnification, 4003) (left panel) and quantification of Mesangial Matrix
n of mean GBM in each group (right panel). Foot processes are indicated by
l data are presented as means ± SEM (n = 4–10/each group) and analyzed by
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Figure 4. Deletion of ROCK1 Prevents Mitochondrial Fission, mtROS, and Glomerular Apoptosis
(A) Quantitative measurement of superoxide generation in isolated mitochondria from kidney glomeruli by EPR spectroscopy (left panel) and bar graph
summarizing the number of apoptotic cells in glomeruli per 50 glomeruli counted in each group (middle panel). Bar graph summarizing caspase-3 activity in
kidney glomeruli in different groups (right panel).
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(Figure 4E). In contrast, the AR ratio in podocytes from diabetic
ROCK1/ was markedly improved and statistically significantly
different from that in diabetic mice (p < 0.01). To further assess
mitochondrial fragmentation in diabetic podocytes, we per-
formed 3D reconstruction of mitochondria from serial sections
of EM micrographs. The mitochondria in WT diabetic mice
were fragmented into short spheres. In contrast, podocytes
from diabetic ROCK1/ exhibited a typical tubular network of
mitochondria by 3D EM (Figure 4F). Similar results were obtained
in db/db:ROCK1/ mice (Figures S2A and S2B).
We next examined mitochondrial morphology in podocytes
from podocin Cre cA-ROCK1 mice. We observed a significant
increase in mitochondrial fission in these mice, as suggested
by a marked decrease in AR ratio (Figures 4G and 4H). Further-
more,mitochondrial Bax (mtBax) levels were increased, whereas
levels of mitochondrial cytochrome c were markedly reduced in
the kidney glomeruli of podocin Cre cA-ROCK1mice (Figures 4I).
Since Dynamin-related protein (Drp) 1 is a key component of
the mitochondrial fission machinery (Jagasia et al., 2005), we
tested whether the effect of ROCK1 on mitochondrial fission
involved Drp1 activation. Mitochondrial recruitment of Drp1
appears to be required for its action on mitochondrial fission
(Chang and Blackstone, 2010); therefore, we examined the
possibility that ROCK1 mediates mitochondrial translocation of
Drp1 in the diabetic milieu. We observed a marked increase in
Drp1 in mitochondria-enriched fractions (mtDrp1) of the kidney
glomeruli of WT diabetic mice (Figure 5A, left panel, and Fig-
ure S2C). The increase in mitochondrial Drp1 levels was abol-
ished in ROCK1/ diabetic mice. Conversely, mtDrp1 was
significantly increased in the kidney glomeruli of podocin Cre
cA-ROCK1 mice (Figure 5A, right panel, and Figure S2C), indi-
cating that ROCK1 plays an important role in remodeling of mito-
chondrial morphology in podocytes, possibly by regulating Drp1
recruitment to the mitochondria in vivo.
ROCK1 Mediates Hyperglycemic-Induced mtROS and
Apoptosis in Podocytes and Kidney Microvascular
Endothelial Cells In Vitro
We next studied the effects of ROCK1 on mtROS, cellular
apoptosis, and mitochondrial fission in cultured cells. We
focused on podocytes and endothelial cells because of strong
colocalization of ROCK1 with markers of podocytes and endo-
thelial cells in the glomeruli (Figure S3A). We simultaneously
measured the effect of ROCK1 on mitochondrial superoxide
production and apoptotic markers by flow cytometry in cultured
podocytes and kidney microvascular endothelial cells (mECs) as(B) Quantitative measurement of superoxide generation (left panel), frequency of
kidney glomeruli from podocin Cre cA-ROCK1 mice by EPR spectroscopy.
(C) Representative western blots (left panel) and bar graphs of Bax (middle panel)
glomeruli in each group. All data are presented as means ± SEM (n = 8–12/each
(D) Representative 2D EM micrographs of mitochondria in podocytes from each
(E) Quantification of mitochondrial aspect ratio in podocytes. A total of 150 mito
(F) Representative 3D EM images of mitochondria in podocytes from STZ-induc
(G) Representative micrographs of mitochondrial morphology in podocytes from
(H) Quantification of mitochondrial aspect ratio from (G).
(I) Representative western blots of mitochondrial Bax (mtBax) and cytochrome c (l
(middle panel) and cytochrome c (right panel) from three independent experiment
otherwise, and analyzed by one-way ANOVA.
Cell Mpreviously described (Mukhopadhyay et al., 2007). The data in
Figure 5B represent the distribution of nonapoptotic, apoptotic,
and dead cells by Annexin V-FITC and Sytox Red staining and
histogram analysis of mean intensity of oxidized MitoSOX Red
in podocytes. Cells were separated into three groups: nonapop-
totic cells (green), early apoptotic cells (purple), and dead cells
(orange). The total fluorescence intensity of oxidized MitoSOX
red measured by flow cytometry is depicted in light blue. High
glucose stimulation (HG, 25 mM for 24–36 hr) increased the
number of apoptotic cells 4-fold (Figure 5C) and induced
2.5-fold increase in the mtROS (Figure 5D) as measured by
MitoSOX Red fluorescence intensity compared to that in normal
glucose (NG, 5 mM) in cultured podocytes. Next, we knocked
down expression of ROCK1 with a specific ROCK1 siRNA
(50 nM, Figure S3B) or used fasudil (10 mmol/l) to assess the
role of endogenous ROCK1. Knockdown of ROCK1 with siRNA
or pharmacological inhibition of ROCK1 with fasudil significantly
decreased the number of apoptotic cells (10% ± 0.05% and
11% ± 0.8% versus 35% ± 2%; p < 0.05) and the production
of mtROS (733 ± 70 and 801 ± 57 versus 1459 ± 73mean fluores-
cence intensity, p < 0.05) (Figures 5B–5D). These data suggest
a critical role for ROCK1 activation in HG-induced mtROS
production and cell apoptosis. Similar data were obtained in
mECs (Figures S3C, S4A, and S4B).
To better understand the role of ROCK1 in HG-induced cellular
apoptosis and its downstream signaling, we first examined the
temporal profile of HG-induced ROCK1 activation in cultured po-
docytes and mECs. ROCK1 activity was significantly increased
after 6hrwithHG treatment (25mM) inbothpodocytes (Figure5E)
and mECs (Figure S5A), suggesting that ROCK1 activation is an
early response to HG stimulation. Mitochondrial fractionation
experiments indicated that mtBax increased and cytochrome c
decreased in cells upon their exposure to HG (Figures 5F and
5G). However, ROCK1 knockdown prevented the effect of HG
on mtBax and cytochrome c. Furthermore, knockdown of
ROCK1 also reversed HG-induced caspase-3 activity in podo-
cytes (Figure 5H), suggesting a critical role for ROCK1 in
HG-induced mitochondrial apoptotic pathway, consistent with
our in vivo studies. Similar resultswere obtained inmECs (Figures
S5B–S5D). Conversely, cA-ROCK1-transfected podocytes ex-
hibited increased mtBax and caspase-3 activity and lower levels
of cytochrome c in mitochondria (Figures 5I and 5J).
ROCK1 Mediates Hyperglycemia-Induced Drp1
Recruitment to the Mitochondria
Wenext examined whether ROCK1 recruitment to themitochon-
dria was necessary for its effect on mitochondrial fission andapoptosis (middle panel), and caspase-3 activity in isolated mitochondria from
and cytochrome c (right panel) of mitochondrial fractions obtained from kidney
group) and analyzed by one-way ANOVA.
group.
chondria in each group from four different animals were evaluated.
ed diabetic ROCK+/+ and diabetic ROCK/ mice.
a control and a podocin Cre cA-ROCK1 knockin mouse.
eft panel) obtained from kidney glomeruli in each group; quantification of mtBax
s. All data are presented as means ± SEM (n = 4–10/each group), unless stated
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Figure 5. ROCK1 Modulates HG-Induced mtROS Production and Podocyte Apoptosis
(A) Representative western blots of mitochondrial Drp1 from kidney glomeruli obtained from diabetic ROCK1+/+ and ROCK1/mice (left panel) and from kidney
glomeruli of podocin Cre cA-ROCK1 knockin mouse (right panel).
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previously described and performed double immunofluores-
cence staining for ROCK1 and MitoTracker, a mitochondrial
marker. ROCK1 did not colocalize to mitochondria in response
to HG (25 mM for 18 hr), and its protein expression was not
detectable in the mitochondrial fractions from HG-stimulated
podocytes in vitro or from kidney glomeruli obtained from STZ-
induced diabetic mice in vivo (Figures S6A and S6B). These
observations suggest that the effect of ROCK1 on mtROS and
apoptosis is not dependent on the recruitment of ROCK1 to
the mitochondria.
Since Drp1 translocation to the mitochondria is a key event in
mitochondrial fission (Jagasia et al., 2005; James and Martinou,
2008; Labrousse et al., 1999), we next tested the possibility that
ROCK1 might exert its effect on mitochondrial fission by
promoting Drp1 translocation to the mitochondria. We initially
examined the effect of ROCK1 on subcellular distribution of
Drp1. We observed that upon stimulation with HG, mitochondria
became short and fragmented, whereas podocytes transfected
with specific siROCK1 or siDrp1 maintained their elongated
mitochondrial morphology in hyperglycemic conditions (Figures
6A and 6B). We further observed that ROCK1 knockdown mark-
edly reduced HG-induced Drp1 recruitment to the mitochondria
in podocytes (Figures 6C and S7A) and in mECs (Figures S7B
and S7C), suggesting that ROCK1 may modulate mitochondrial
fission through Drp1 translocation to the mitochondria. To
confirm the effect of ROCK1 on mitochondrial dynamics,
we next examined the effect of ROCK1 overexpression on
mitochondrial fission. Whereas podocytes transfected with
cA-ROCK1 exhibited more fragmented mitochondria with
amarked increase in Drp1 recruitment to themitochondria under
normal glucose (NG, 5 mM) conditions, this fragmented pheno-
type was reversed when Drp1 was knocked down by a lentiviral
Drp1 short hairpin RNA (shRNA) (Figures 6D–6F and S7D).
Notably, simultaneous analysis of measured superoxide produc-
tion and apoptosis revealed that podocytes cotransfected with
cA-ROCK1 and Drp1 shRNA had lower levels of mtROS and
exhibited less cellular apoptosis (Figure 6G). Taken together,
these data indicate that ROCK1 may promote mitochondrial
fission, mtROS production, and cellular apoptosis through
Drp1 translocation to the mitochondria.
ROCK1Mediates Drp1 Recruitment to the Mitochondria
by Phosphorylating Drp1 at Serine 600 Residue
Because virtually nothing was known about the effect of ROCK1
on regulating subcellular localization of Drp1, we sought to(B) Representative histograms of flow cytometry experiments depicting simultan
cultured podocytes. The changes in the number of apoptotic cells (% annexin V-F
in total (blue), normal (green), apoptotic (purple), and dead (orange) cells are dep
siRNA.
(C and D) Quantitative data expressing% of annexin V-FITC-positive cells (C) and
conditions.
(E) Representative western blot of temporal profile of ROCK1 activity in HG (25 m
(F) Representative western blots of mitochondrial Bax and cytochrome c in the c
(G) Quantitative analysis of mitochondrial Bax and cytochrome c from three inde
(H) Quantitative changes in caspase-3 activity from three independent experime
(I) Representative western blots of mitochondrial Bax and cytochrome c in cA-R
(J) Quantitative changes of caspase-3 activity in cA-ROCK1-transfected podoc
experiments, unless stated otherwise, and analyzed by one-way ANOVA.
Cell Mdefine the regulatory mechanisms by which ROCK1 activated
Drp1. We initially questioned whether ROCK1 can interact with
Drp1 in response to HG stimulation in intact cells. Transfected
mECs expressing Flag-Drp1 or ROCK1 or coexpressing both
plasmids were stimulated with HG (25 mM). Immunoprecipita-
tion of cell lysates with an anti-Flag antibody, followed by
western blot analysis, revealed that ROCK1 and Drp1 were
coimmunoprecipitated when cells were treated with HG for
5 hr (Figure 7A), indicating that ROCK1 and Drp1 are closely
associated under hyperglycemic conditions.
The ability of ROCK1 to associate with Drp1, in response to
hyperglycemic stimulation, led us to examine whether Drp1
might be a direct substrate of ROCK1. We tested the possibility
that ROCK1, a serine/threonine kinase, can induce phospho-
rylation of Drp1 at a serine residue and whether serine phos-
phorylation of Drp1 could have mediated the effect of ROCK1
on Drp1 recruitment to the mitochondria. In support of our
hypothesis, previous published work has shown that a series
of kinases can influence subcellular localization of Drp1 by
phosphorylating two main conserved serine residues of Drp1
(Chang and Blackstone, 2007b, 2010). Based on the consensus
sequence motif of ROCK substrates (R/K-X-X-S/T or R/K-X-
S/T, where R is arginine; K, lysine; S, serine; and T, threonine)
(Kang et al., 2007), we identified Ser600 in the mouse Drp1
isoform b as a potential phosphorylation site for ROCK1 (Fig-
ure 7B). This serine phosphorylation site is highly conserved
among species and is located at the GTPase effector domain
(GED) of Drp1 (Figure 7B). Using phosphospecific Drp1
antibodies, we observed that HG stimulation (25 mM for
36 hr) increased phosphorylation of Drp1 at Ser600 (corre-
sponding to Ser637 in human Drp1 isoform 1) (Figure 7C).
ROCK1 knockdown, either by using dominant-negative
ROCK1 (dnROCK1) or siROCK1, attenuated Drp1 phosphoryla-
tion at Ser600, but not at Ser579, another regulatory phospho-
serine site of Drp1 (corresponding to Ser616 in human Drp1
isoform 1) (Figure 7C).
To determine whether Ser600 was the precise site for phos-
phorylation by ROCK1 in vitro, we performed an in vitro kinase
assay using bacterially expressed Drp1 as a substrate for puri-
fied ROCK1. ROCK1 protein was labeled with [g-32P]ATP
in vitro, and Drp1 phosphorylation was assessed in WT Drp1
or a Drp1 mutant protein (S600A) where Ser600 was replaced
with alanine. As shown in Figure 7D, we observed that ROCK1
was able to phosphorylate WT Drp1 protein but not Drp1
S600A protein in vitro. These data indicate that ROCK1 specifi-
cally phosphorylates Drp1 at the Ser600 residue.eous detection of apoptosis and mitochondrial superoxide production in live
ITC positive) and superoxide production (MitoSOX Red) fluorescence intensity
icted in each condition following HG treatment for 24 hr. Sc-siRNA: scrambled
mean fluorescence intensity of MitoSOX Red (D) in response to HG in different
M)-treated podocytes.
ultured mouse podocyte in different conditions.
pendent experiments.
nts.
OCK1-transfected cultured podocytes.
ytes. The data are presented as means ± SEM of at least three independent
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Figure 6. ROCK1 Mediates HG-Induced Mitochondrial Fission
(A) Double immunofluorescence of MitoTracker and Drp1 using deconvolution microscopy. Cells were transfected with scrambled siRNA, si-Drp1, or si-ROCK1.
MitoTracker, red; DAPI, blue; Drp1, green; merge, yellow. Magnification, 31000. Scale bars, 5 mm.
(B) Mitochondrial morphology was assessed by aspect ratio analysis. The morphology of at least 120 mitochondria was determined in a triplicate and blinded
manner.
(C) Representative immunoblot analysis of mitochondrial Drp1 (mtDrp1) in cultured mouse podocytes transfected with si-ROCK1 or scrambled (sc) siRNA or
treated with fasudil (10 mmol/l).
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ylation, we next assessed the contribution of Ser600 phosphor-
ylation on Drp1 recruitment to the mitochondria. Two recent
publications have provided seemingly contradictory data on
the functional consequences of Drp1 phosphorylation at
Ser600. Whereas one study reported that phosphorylation of
Drp1 at Ser637/656 (human/rat) (corresponding to Ser600 in
mouse Drp1 isoform b) decreased Drp1 recruitment to the mito-
chondria (Chang and Blackstone, 2007a), a more recent report
demonstrated that phosphorylation of the same site in human
Drp1 isoform 3 by the Ca2+/calmodulin-dependent protein
kinase Ia (CaMKIa) enhanced Drp1 recruitment to the mitochon-
dria and increased mitochondrial Drp1 abundance (Han et al.,
2008). We tested the effect of phosphorylation of Drp1 at
Ser600 on its subcellular localization by transfecting podocytes
with Flag-Drp1 (WT) or Flag-Drp1 S600A. We found that
HG (25 mM for 36 hr) induced a significant increase in Drp1
recruitment to the mitochondria, which was reduced in cells
transfected with Drp1 S600A (Figure 7E), suggesting that
ROCK1-mediated phosphorylation of Drp1 at the Ser600 site
promotes Drp1 translocation to the mitochondria. Furthermore,
to assess the effect of Drp1 phosphorylation at Ser600 on
mitochondrial fission, we knocked down endogenous Drp1 in
podocytes using a lentiviral Drp1 shRNA and analyzed the mito-
chondrial morphology in cells transfected with either an empty
vector, WT Drp1, or S600A mutant of Drp1. Whereas HG-
induced cells transfected with Drp1 shRNA had long mitochon-
dria, cells transfected with WT Drp1 exhibited short punctate
mitochondria (Figures 7F and S7E). Conversely, cells transfected
with Drp1 S600A exhibited a significant shift from the frag-
mented phenotype to elongated mitochondria (Figure 7F, right
panel), suggesting a direct effect of Drp1 phosphorylation at
Ser600 on mitochondrial fission. Consistent with these results,
Drp1 knockdown in HG-treated cells expressing Drp1 S600A
decreased cellular apoptosis compared with cells expressing
WT Drp1 (Figure 7G). Importantly, podocytes transfected with
a phosphomimetic version of Drp1 (Drp1 S600D) showed
a marked increase in mitochondrial fragmentation (Figure 7H).
These gain-of-function experiments support the previously
described loss-of-function experiments and indicate a critical
role of ROCK1 in mitochondrial fission by promoting phosphor-
ylation of Drp1 at Ser600.
DISCUSSION
The role of ROCK1 isoform in the pathogenesis of DN is
unknown. Furthermore, almost nothing is known about the effect
of ROCK1 on mitochondrial remodeling or the molecular
mechanisms by which ROCK1 could potentially modulate mito-
chondrial dynamics. In order to address these questions, we
generated two diabetic ROCK1 knockout mice and an inducible
podocyte-specific ROCK1 knockin mouse model to study the(D)Micrographs of mitochondrial morphology visualized byMitoTracker red stainin
Scale bars, 15 mm.
(E) Mitochondrial morphology was assessed by aspect ratio from three independ
(F) Representative western blot ofmitochondrial Drp1 (mtDrp1) in culturedmouse
(G) Quantitative data expressing % of annexin V-FITC-positive cells (left pan
means ± SEM of at least three independent experiments analyzed by one-way A
Cell Mspecific role of ROCK1 and its downstream signaling on mito-
chondrial fission and on progression of DN. Our results indicate
that diabetic ROCK1 null mice exhibit significant reduction in
albuminuria, while inducible podocyte-specific cA-ROCK1
knockin mice had higher levels of albuminuria. We identified
Drp1 as a direct substrate for ROCK1 and provide the evidence
that ROCK1-mediated phosphorylation of Drp1 at Ser600
contributes to enhanced mitochondrial fission.
Mitochondrial fission has been previously implicated as a crit-
ical mediator of increased ROS production in hyperglycemic
conditions (Brooks et al., 2009), but the key signaling events
linking hyperglycemia with increased mitochondrial ROS
production have remained elusive. We now report that hypergly-
cemia-induced mitochondrial fission depends on both ROCK1
activation and Drp1 translocation to the mitochondria. This
ROCK1-dependent metabolic pathway involves phosphoryla-
tion of Drp1 at Ser600, which promotes its recruitment to the
mitochondria. These findings provide a clear link between hyper-
glycemia and increased ROS generation via a previously unrec-
ognized signaling pathway, which involves ROCK1 activation,
Drp1 phosphorylation, and Drp1 recruitment to the mitochon-
dria, leading to increased mitochondrial fission and cellular
apoptosis.
Drp1 phosphorylation is one of the key regulatory posttransla-
tional modifications of Drp1, whichmodulates its translocation to
the mitochondria (Chang and Blackstone, 2007b; Cribbs and
Strack, 2007). However, despite the central importance of
Drp1 phosphorylation in mitochondrial fission, the functional
consequences of the two conserved serine phosphorylation
sites on Drp1 activation remain incompletely understood. For
example, while PKA phosphorylation of Drp1 at Ser637/656
(human/rat) decreases Drp1 GTPase activity (Chang and Black-
stone, 2007a; Cribbs and Strack, 2007), phosphorylation of the
same conserved serine residue in Drp1 isoform 3 by CaMKIa
causes a significant increase in Drp1 recruitment to the mito-
chondria (Han et al., 2008). Our interpretation of these seemingly
contradictory observations is that the functional consequences
of serine phosphorylation of Drp1 could be highly cell-type
and/or stimulus dependent. In our experimental models,
ROCK1-mediated Ser600 phosphorylation (mouse Drp1 isoform
b) resulted in Drp1 translocation to the mitochondria, similar to
the effect of CaMKIa, leading to enhanced cellular apoptosis.
These findings, nevertheless, do not exclude that other
ROCK1-dependent pathways, independent of Drp1 phosphory-
lation, may also play important roles in the ROCK1-mediated
cellular response to metabolic stress, and they do not exclude
that the effect of ROCK1 on progression of DNmay bemediated,
at least in part, through other pathways.
Collectively, the findings of this study provide significant
insights into the pathobiology of ROCK1 in the diabetic milieu.
First, we propose a role for ROCK1 in hyperglycemic-induced
mitochondrial fission. Second, we identify Drp1 as a directg of podocytes transfectedwith cA-ROCK1, Drp1 shRNA, or scramble shRNA.
ent experiments (>100 mitochondria).
podocytes transfected with cA-ROCK1, Drp1 shRNA, or scrambled (sc) shRNA.
el) and MitoSOX Red (right panel) in different conditions. In all figures, the
NOVA are shown.
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Figure 7. ROCK1 Promotes Mitochondrial Fission via Drp1 Phosphorylation at Ser600
(A) Western blots of immunoprecipitates with anti-Flag antibody (IP) and whole-cell lysates (WCL) of ROCK1 and Flag-Drp1 immunoblotted with anti-ROCK1 or
anti-Drp1 antibodies in mECs treated with normal glucose (NG, 5 mM) or high glucose (HG, 25 mM) for 1 and 5 hr.
(B) Domain structure of mouse Drp1 isoform b. Sequences from several Drp1 isoforms were aligned to show the conserved motifs for Cdk1/PKCd phosphor-
ylation (inverted triangle) and PKA/CaMKIa phosphorylation (asterisk) sites.
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ROCK1 and Mitochondrial Dynamicssubstrate for ROCK1. Third, we identify the precise ROCK1-
mediated phosphorylation site of Drp1, and finally, we provide
direct evidence for a role of ROCK1 in progression of DN. These
findings demonstrate an unexpected role for ROCK1 in mito-
chondrial fission. Although the expression of ROCK2 in
ROCK1/ glomeruli was unaltered, a role for ROCK2 on mito-
chondrial dynamics cannot be completely ruled out.
In conclusion, our findings define a metabolic pathway by
which ROCK1 activation promotes mitochondrial fragmentation
under high-glucose conditions and provide insights into the role
of ROCK1 in a signaling cascade involving Drp1 activation and
mitochondrial remodeling.
EXPERIMENTAL PROCEDURES
Animals
All animal studieswere carried outwith approval of the Institutional AnimalCare
and Use Committee (IACUC) of Baylor College of Medicine. Generation and
characterization of ROCK1/ mice have been previously described (Zhang
et al., 2006). Since db/db mice are infertile, to generate db/db:ROCK1/
double mutant mice, FVB db/+ (Jackson Laboratory, Bar Harbor, ME) mice
were initially mated with FVB ROCK/ mice, and then db/+:ROCK1+/ were
crossed with ROCK1/ mice, and finally db/+:ROCK1/ mice were inter-
crossed to generate db/db:ROCK1/ double mutant mice. To create an
inducible constitutively active (cA) ROCK1 knockin mouse, a cA mutant of
ROCK1 (human D3 cA-ROCK1) was used to generate the cA-ROCK1 knockin
targeting vector (Fujisawa et al., 1996). The ubiquitin C promoter was used to
drive cA-ROCK1 cDNA expression only when the loxP-stop-loxP is removed.
A neo cassette driven by a PGK promoter was used to facilitate selection of
positive embryonic stem cell (ESC) clones. FRT sequences were recognized
by FLP recombinase. We generated chimeras by blastocyst injection of
ESCs. After germline transmission, the mice were crossed to C57BL/6J mice
expressing FLP recombinase to remove the neo cassette.
Plasmid DNA and siRNA
Mouse Drp1 S600A and S600Dmutations were achieved by using PCR-based
mutagenesis with the following primers, respectively: CCAGTTG CAAGAAA
GCTAGCTGCCCGAGAACAGCGAGAT (forward) and AAAACTGGAT GCCCG
AGAACAG (reverse). C-terminal mouse Drp1 (isoform b, 490–699) was ampli-
fied by PCR from the cDNA clone (OpenBiosystems) using the following primer
set: GTGAATTCGAGCTAGCGTATATCAACACAAAACACCCC (forward) and
AGG GATCCTCACCAAAGATGAGTCTCTCGGATTTCAGC (reverse), and
subcloned between EcoRI and BamHI sites of pGTK3XF vector. siRNAs for
ROCK1, Drp1, Bax, and scramble siRNA controls were purchased from
Thermo Scientific (Chicago, IL). Transfections were performed using Lipofect-
amine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer’s protocols.
Generation of Drp1 Knockdown Stable Cells
Mouse Drp1 shRNA lentiviral particle and the scramble shRNA lentiviral
particle were purchased from Santa Cruz Biotechnology. These viral particles
were used to infect undifferentiated podocytes with 8 mg/ml polybrene (Sigma)
and were subsequently selected with 2 mg/ml puromycin (Sigma) in the pres-
ence of 20 U/ml IFN-g at 33C.(C) Western blots of phospho-Drp1 (Ser600 and Ser579) and total Drp1.
(D) In vitro kinase assay of bacterially expressed WT C-terminal Drp1 (490–699) a
staining of Drp1 was used as the input loading control.
(E) Western blots of mitochondrial and cytosolic fractions of Drp1 in mECs follow
(25 mM) for 36 hr.
(F) Micrographs of mitochondrial morphology visualized by MitoTracker red stain
bars, 15 mm. The bottom images showmagnifications of the areas outlined in the t
experiments (>100 mitochondria) (right panel).
(G) Quantitative data expressing % of annexin V-FITC-positive cells in different c
(H) Mitochondrial morphology was visualized by MitoTracker red staining of podo
images show magnifications of the areas outlined in the images above. Quan
(>100 mitochondria) (right panel). Results are presented as means ± SEM of at le
Cell MIn Vitro Kinase Assay
Recombinant GST-Drp1 proteins were purified using glutathione sepharose
(GE Healthcare) according to the manufacturer’s protocol and digested with
PreScission protease (GE Healthcare) to remove the GST-tag. One microgram
of WT Drp1 or S600Amutant was incubated with 0.1 mg purified active ROCK1
(GST fusion of amino acids 17–535 of human ROCK1, Abcam) in a 30 ml reac-
tion buffer (25 mMTris [pH 7.5], 10mMMgCl2, 0.5 mMEGTA, 0.5 mMNa3VO4,
5 mM b-glycerophosphate, 2.5 mM DTT, 0.01% Triton X-100, 100 mM ATP,
and 10 mCi [g-32P]ATP). After 30 min incubation at 37C, reactions were
stopped by adding SDS sample buffer to 13 and separated by 12% SDS-
PAGE.
Flow Cytometry
Detection of apoptosis and mitochondrial superoxide production was per-
formed as previously described (Mukhopadhyay et al., 2007). Samples were
analyzed using BD FACSCantoII flow cytometer (BD Biosciences, CA) at the
BCM Cell Sorting Facility.
Mitochondrial Fragmentation
The aspect ratio was calculated as previously described (Brooks et al., 2007,
2009; Yu et al., 2006).
Statistical Analysis
The data are summarized as the mean ± SEM. Statistical significance was as-
sessed by performing analysis of variance (ANOVA) followed by the Tukey-
Kramer post hoc analysis for multiple comparisons using an a value of 0.05
in GraphPad Prism software (San Diego, CA).
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